Magnolia Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Magnolia Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$240K	Sell	4,160 -140	-3%	-$8.04K	0.04%	267
2026 Q1	$261K	Sell	4,300 -1,105	-20%	-$64.4K	0.05%	254
2025 Q4	$292K	Buy	+5,405	New	+$260K	0.06%	233
2025 Q3	–	Sell	-4,491	Closed	-$208K	–	235
2025 Q2	$208K	Buy	4,491 +514	+13%	+$25.2K	0.05%	228
2025 Q1	$243K	Buy	3,977 +3	+0.1%	+$175	0.07%	207
2024 Q4	$225K	Buy	+3,974	New	+$222K	0.06%	215

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Magnolia Capital Advisors's BMY Position: Q2 2026 in Review

Magnolia Capital Advisors reduced its Bristol-Myers Squibb (BMY) stake by 3.3% in Q2 2026, selling an estimated $8.04K and leaving 4,160 shares worth $240K. The position accounts for 0.04% of the portfolio, ranked #267.

Magnolia Capital Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $292K in Q4 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Magnolia Capital Advisors held 4,160 shares of Bristol-Myers Squibb worth $240K as of Q2 2026.
Magnolia Capital Advisors sold 140 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.04K.
Bristol-Myers Squibb made up 0.04% of Magnolia Capital Advisors's portfolio in Q2 2026, its #267 holding.
Magnolia Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
Magnolia Capital Advisors's Bristol-Myers Squibb position peaked at $292K in Q4 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Magnolia Capital Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.